National trends in rate of patients hospitalized for heart failure and heart failure mortality in France, 2000-2012
National trends in rate of patients hospitalized for heart failure and heart failure mortality in France, 2000-2012
复制标题
DOI：
10.1002/ejhf.284
复制
发表时间：
2015-06-01
影响因子：
18.2
通讯作者：
Olie, Valerie
中科院分区：
文献类型：
--
作者：
Gabet, Amelie;Juilliere, Yves;Olie, Valerie
目的 本研究的目的是描述 2000 年至 2012 年间法国因心力衰竭 (HF) 住院患者和心力衰竭相关死亡率的年度趋势。方法和结果出院数据取自法国国家住院数据库 (PMSI)。死亡率数据来自法国国家死亡率数据库。选择构成潜在或相关死亡原因的心力衰竭事件。使用 2010 年欧洲人口普查人口作为标准人口，对比率进行年龄标准化。使用泊松回归模型测试时间趋势。 2012年，因心力衰竭住院的总体年龄标准化患者率为每10万居民246.2人。 2010 年，年龄标准化的心力衰竭相关死亡率为每 10 万居民 113.8 例。2002 年至 2012 年间，住院患者比率保持稳定，而死亡率从 2000 年至 2010 年每年下降 3.3%。住院患者和死亡率的趋势在男性和女性之间存在显着差异，特别是在 45 岁至 55 岁和 65 岁至 65 岁之间。 74岁年龄组，女性下降幅度较小。结论男性中，因心力衰竭住院的患者略有下降，死亡率大幅下降。在女性中，仅观察到心力衰竭死亡率大幅下降。心力衰竭仍然是法国死亡和住院的主要原因之一，尤其是老年人。
AimsThe objectives of this study were to describe annual trends in patients hospitalized for heart failure (HF) and HF-associated mortality rates in France between 2000 and 2012.Methods and resultsHospital discharge data were extracted from the French National Hospitalization Database (PMSI). Mortality data were obtained from the French National Mortality Database. HF events constituting the underlying or associated cause of death were selected. Rates were age standardized using the 2010 European census population as the standard population. Time trends were tested using a Poisson regression model. In 2012, the overall age-standardized rate of patients hospitalized for HF was 246.2 per 100 000 inhabitants. The age-standardized rate of HF-associated mortality was 113.8 per 100 000 inhabitants in 2010. Hospitalized patient rates remained steady between 2002 and 2012, whereas mortality decreased by 3.3% annually from 2000 to 2010. Trends in hospitalized patients and mortality differed significantly between men and women, particularly among the 45- to 55- and 65- to 74-year-old age groups, with a smaller decrease observed in women.ConclusionAmong men, a slight decrease in patients hospitalized for HF and a substantial reduction in mortality were observed. Among women, only a large decrease in HF mortality was observed. HF remains one of the leading causes of death and hospitalization in France, particularly in the elderly.